Valuation: Cannabis Bioscience International Holdings, Inc.

Market Cap 2.37M 2.03M 1.9M 1.74M 3.27M 227M 3.31M 22.46M 8.73M 114M 8.89M 8.7M 377M P/E 2024
-9.52x
P/E 2025 -11.8x
Enterprise Value 3.37M 2.89M 2.7M 2.47M 4.66M 322M 4.71M 31.95M 12.42M 162M 12.65M 12.37M 536M EV / Sales 2024
28.9x
EV / Sales 2025 25.6x
Free-Float
41.59%
Yield 2024 *
-
Yield 2025 -
15/07 Cannabis Bioscience International Holdings Receives Texas License for Consumable Hemp Products CI
17/04 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2026 CI
20/02 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2025 CI
23/10/25 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the First Quarter Ended August 31, 2025 CI
07/10/25 Cannabis Bioscience International Holdings, Inc Appoints Andy Trivedi to Its Board of Directors CI
23/09/25 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Full Year Ended May 31, 2025 CI
22/09/25 Cannabis Bioscience International Holdings, Inc. Auditor Raises 'Going Concern' Doubt CI
22/04/25 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2025 CI
22/01/25 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2024 CI
07/01/25 Cannabis Bioscience International Holdings Announces Partnership with Stephen Gould for Manufacturing and Distribution of Medical Products CI
27/12/24 Cannabis Bioscience International Holdings, Inc. announced that it has received $0.075 million in funding CI
27/11/24 Cannabis Bioscience International Holdings, Inc. Appoints Charles Tamburello as Directors, Effective December 1, 2024 CI
26/11/24 Cannabis Bioscience International Holdings, Inc. Unveils the Future of Wellness with Revolutionary Anti-Aging Chip CI
1 week-33.33%
Current month-33.33%
1 month-50.00%
3 months-66.67%
6 months-75.00%
Current year-80.00%
1 week 0
Extreme 0.0001
0
1 month 0
Extreme 0.0001
0
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0.01
10 years 0
Extreme 1.0E-6
0.27
Manager TitleAgeSince
Chief Executive Officer 70 19/12/2019
Treasurer 61 06/05/2024
Corporate Secretary 66 19/12/2019
Director TitleAgeSince
Director/Board Member 70 19/12/2019
Director/Board Member 66 19/12/2019
Director/Board Member 61 06/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-33.33%-80.00%-83.33% 1.21M
+0.48%+3.78%+3.74%+23.10% 51.21B
+1.01%-0.20%+471.68%+564.93% 45.35B
+0.16%+7.88%+36.14%+20.76% 42.84B
-0.66%+2.61%+18.59%+87.04% 42.29B
+0.88%-3.48%+17.20%+53.83% 32.15B
-0.12%+3.84%+33.73%+145.25% 17.31B
-0.53%+1.84% - - 16.55B
-0.25%+4.97%+9.56%+30.90% 14.84B
+1.15%+4.17%+84.49%+50.33% 14.25B
Average +0.21%-0.43%+66.13%+99.20% 27.68B
Weighted average by Cap. +0.28%+3.07%+101.44%+141.38%

Financials

2024 2025
Net sales 249K 213K 200K 182K 344K 23.83M 348K 2.36M 918K 11.96M 934K 914K 39.59M 303K 260K 243K 222K 419K 29.02M 424K 2.87M 1.12M 14.57M 1.14M 1.11M 48.21M
Net income -651K -558K -522K -477K -901K -62.37M -911K -6.18M -2.4M -31.32M -2.45M -2.39M -104M -549K -470K -440K -402K -759K -52.55M -767K -5.21M -2.02M -26.39M -2.06M -2.02M -87.31M
Net Debt 939K 805K 753K 689K 1.3M 89.94M 1.31M 8.91M 3.47M 45.16M 3.53M 3.45M 149M 1M 857K 802K 733K 1.38M 95.79M 1.4M 9.49M 3.69M 48.1M 3.76M 3.67M 159M
Logo Cannabis Bioscience International Holdings, Inc.
Cannabis Bioscience International Holdings, Inc. is engaged in the provision of services in therapeutic areas of clinical research. The Company provides educational systems focused on medical cannabis in the United States and Latin America, as well as worldwide through online education, services in therapeutic areas of clinical trials. Through its Alpha Research Business, based in Houston, Texas, it offers specialized services in all therapeutic areas of clinical trials and has conducted over 20 clinical trials for Sponsors and CROs. Through the Pharmacology University Business, it provides knowledge and promotes professionalism in the worldwide cannabis industry through education in and research about the medical properties and healing virtues of this substance. It offers multilevel educational services to entrepreneurs, medical and legal professionals, cultivators, dispensary technicians, manufacturers, patients, and others who desire to participate in the cannabis industry.
Employees
2
Date Price Change Volume
24/08/26 USD 0.000100 0.00% 5,010,000
21/08/26 USD 0.000100 -33.33% 500
20/08/26 USD 0.000150 -25.00% 500,000
19/08/26 USD 0.000200 +33.33% 1,500,000
  1. Stock Market
  2. Stocks
  3. CBIH Stock